The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference
Abstract
Observational and clinical trial data have accrued to show that acute/chronic heart disease can directly contribute to and/or accelerate acute/chronic worsening kidney function and vice versa. A description of the epidemiology of heart–kidney interaction, as defined by the proposed consensus cardio-renal syndrome (CRS) definitions, is a critical initial step towards understanding not only the overall burden of disease for each of the proposed CRS subtypes, but also their natural history, associated morbidity and mortality and potential health resource implications [1]. Importantly, these CRS subtypes may have important discriminating features in terms of predisposing or precipitating events, risk identification, natural history and outcomes. Likewise, a surveillance of the epidemiology is vital for determining whether there exist important gaps in knowledge and for the design of future epidemiologic investigations and clinical trials. Accordingly, this article will summarize the epidemiology of CRS. Refer to supplementary file. This syndrome is characterized by acute worsening of heart function leading to acute kidney injury (AKI) and/or dysfunction. The spectrum of acute cardiac events that may contribute to AKI and the development of acute cardio-renal syndrome (Type 1 CRS) include acute decompensated heart failure (ADHF), acute coronary syndrome (ACS), cardiogenic shock and cardiac surgery-associated low cardiac output syndrome. There is a large body of literature that has examined AKI attributable to acute worsening of heart function, in particular for ADHF and ACS (Tables 2 and 3). Most are retrospective, secondary and/or posthoc analyses from large databases [2–8] or clinical trials of drug therapy [9,10]. Few were prospective [11–15]. Summary of studies fulfilling criteria for Type 1 CRS with a presenting diagnosis of ADHF SCr, serum creatinine; m, months; d, days; CV, cardiovascular; LOS, length of stay. Summary of studies fulfilling criteria for Type 1 CRS with a presenting diagnosis of ADHF SCr, serum creatinine; m, months; d, days; CV, cardiovascular; LOS, length of stay. Summary of studies fulfilling criteria for Type 1 CRS with a presenting diagnosis of ACS WRF, worsening renal function; SCr, serum creatinine; wks, weeks; m, months; CKD, chronic kidney disease; ESKD, end-stage kidney disease. Summary of studies fulfilling criteria for Type 1 CRS with a presenting diagnosis of ACS WRF, worsening renal function; SCr, serum creatinine; wks, weeks; m, months; CKD, chronic kidney disease; ESKD, end-stage kidney disease. The term ‘worsening renal function’ (WRF) has been regularly used to describe the acute and/or sub-acute changes that occur to kidney function following ADHF or ACS (Table 1). The incidence estimates for WRF associated with ADHF and ACS have ranged between 24–45 and 9–19%, respectively. A small single-centre study found that AKI occurred in 48% of paediatric patients admitted for ADHF [16]. The broad range in reported incidence is largely attributable to variations in the definitions of WRF, differences in the observed time-at-risk and the heterogeneity of selected populations being studied (Table 1). Proposed summary of operational definitions to be used when describing the epidemiology of CRS HF, heart failure; LVEF, left ventricular ejection fraction; ESC, European Society of Cardiology; AHA, Alberta Heart Association; ACC, American College of Cardiology; TIA, transient ischaemic attack; SCr, serum creatinine; GFR, glomerular filtration rate. Proposed summary of operational definitions to be used when describing the epidemiology of CRS HF, heart failure; LVEF, left ventricular ejection fraction; ESC, European Society of Cardiology; AHA, Alberta Heart Association; ACC, American College of Cardiology; TIA, transient ischaemic attack; SCr, serum creatinine; GFR, glomerular filtration rate. Many studies used variable durations of observed time-at-risk for ascertainment of WRF. Most commonly, criteria for WRF were fulfilled if the defined changes to kidney function occurred within hospital admission [4,5,15]. This is problematic when considering the variation in duration of hospital stay both between individual patient admissions and between studies. Other studies observed for WRF for 2 weeks [9] and up to 6 months [17]. These variations in observed time-at-risk for WRF have the potential to introduce bias and misclassification. In ADHF, Gottlieb et al. showed that 47% had WRF within 3 days of hospital admission [4], while Cowie et al. found that 50% occurred within 4 days [11]. Both Cowie et al. and Krumholz et al. showed that 70–90% of all WRF had occurred within the first week of hospital admission [5,11]. Likewise, two studies have shown that the time to peak change in serum creatinine (SCr) had occurred within 5 days of hospital admission [13,14]. Goldberg et al. found that 75% of AKI occurring in association with ACS occurred within 3 days after hospital admission [3]. Accordingl
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
Hillege, H. L., Nitsch, D., Pfeffer, M. A., Swedberg, K., McMurray, J. J. V., Yusuf, S., Granger, C. B., Michelson, E. L., Östergren, J., Cornel, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.580506 · Cited by 945
Self-citation
Cited by
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Self-citationHeart failure and kidney dysfunction: epidemiology, mechanisms and management
Schefold, J. C., Filippatos, G., Hasenfuss, G., Anker, S. D., & von Haehling, S. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.113 · Cited by 671
Self-citationRonco, C., Cicoira, M., & McCullough, P. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.077 · Cited by 422
Self-citationUpadhya, B., Rocco, M., Lewis, C. E., Oparil, S., Lovato, L. C., Cushman, W. C., Bates, J. T., Bello, N. A., Aurigemma, G., Fine, L. J., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003613 · Cited by 118
“plication, and its prevalence increases with declining kidney function.(17) In both blacks and those with CKD, studies suggest”
Metadata
- Authors
- Bagshaw, S. M., Cruz, D. N., Aspromonte, N., Daliento, L., Ronco, F., Sheinfeld, G., Anker, S. D., Anand, I., Bellomo, R., Berl, T., Bobek, I., Davenport, A., Haapio, M., Hillege, H., House, A., Katz, N., Maisel, A., Mankad, S., McCullough, P., Mebazaa, A., Palazzuoli, A., Ponikowski, P., Shaw, A., Soni, S., Vescovo, G., Zamperetti, N., Zanco, P., Ronco, C., & for the Acute Dialysis Quality Initiative (ADQI) Consensus Group
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02-25
- Volume
- 25
- Issue
- 5
- Pages
- 1406-1416
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2167939344
- Cited by
- 234
- References
- 3
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. https://app.cochat.ai/papers/10.1093/ndt/gfq066
- The paper
- Bagshaw, S. M., Cruz, D. N., Aspromonte, N., Daliento, L., Ronco, F., Sheinfeld, G., Anker, S. D., Anand, I., Bellomo, R., Berl, T., Bobek, I., Davenport, A., Haapio, M., Hillege, H., House, A., Katz, N., Maisel, A., Mankad, S., McCullough, P., . . . for the Acute Dialysis Quality Initiative (ADQI) Consensus Group. (2010). Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfq066
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.